IL1B and asthma: The anti-inflammatory potential of carvacrol is reported in different models of inflammation, such as IL-1β-stimulated chondrocytes [116], rheumatoid arthritis [117], carcinogenicity associated inflammation in rat colon [118], tonsil epithelial cells [119], paw edema animal model [120], LPS-activated HL-1 cardiomyocytes [121], ovalbumin-induced asthma animal model [122], encephalomyelitis [123] and MNNG-induced gastric carcinogenesis [124].